FDA Review of DASATINIB.ppt

FDA Review of DASATINIB Oncology Drug Advisory Committee (ODAC) June 2, 2006 Review teams Clinical - Michael Brave, M.D., Vicki Goodman, M.D., Edvardas Kaminskas, M.D., Ann T. Farrell, M.D. , and Robert Justice, M.D. Statistical - Janet Jiang, Ph.D., and Raji Sridhara, Ph.D. Chemistry- William Timmer, Ph. D., Ravi Haranpanalli, Ph.D., and Richard Lostritto, Ph.D. Pharmacology/Toxicology- Haleh Saber-Mahloogi Ph.D., and David Morse, Ph.D. Clinical Pharmacology- Angela Men, Ph.D., Leslie Kenna, Pharm. D., Julia Bullock, Ph.D., and Brian Booth, Ph.D. Project Management- Amy Baird, B.A. Overv